Patient demographics
| . | Total (N = 329) . | |
|---|---|---|
| Missing (%) . | N (%)∗ . | |
| Patient sex | ||
| Male | 0 | 223 (67.8) |
| Female | 0 | 106 (32.2) |
| IEI subgroup | ||
| CID | 0 | 163 (49.5) |
| PD | 0 | 127 (38.6) |
| PAD | 0 | 39 (11.9) |
| Age at HSCT (y) | ||
| Median (IQR) | 0 | 18.4 (16.6-22.8) |
| Time from clinical diagnosis to HSCT (mo) | ||
| Median (IQR) | 1 (0.3) | 63.1 (13-189.1) |
| Age at clinical diagnosis (y) | ||
| Median (IQR) | 3 (0.9) | 13 (3.6-17.2) |
| BMI at HSCT | ||
| Low BMI (<18) | 34 (10.3) | 74 (25.1) |
| Normal/high BMI (≥18) | 221 (74.9) | |
| Infection immediately prior to HSCT | ||
| No | 45 (13.7) | 136 (47.9) |
| Yes | 148 (52.1) | |
| Bronchiectasis at HSCT | ||
| Absent | 5 (1.5) | 238 (73.5) |
| Present | 86 (26.5) | |
| Colitis or protracted diarrhea at HSCT | ||
| Absent | 4 (1.2) | 255 (78.5) |
| Present | 70 (21.5) | |
| Malignancy prior to HSCT† | ||
| No | 5 (1.5) | 263 (80.9) |
| Yes | 62 (19.1) | |
| Remission status at HSCT (if prior malignancy) | ||
| No remission | 4 (5.6) | 23 (39.7) |
| Remission | 33 (56.9) | |
| Not evaluated | 2 (3.4) | |
| GLILD at HSCT | ||
| No | 18 (5.5) | 268 (86.2) |
| Yes | 43 (13.8) | |
| Splenectomy prior to HSCT | ||
| No | 14 (4.3) | 285 (90.5) |
| Yes | 30 (9.5) | |
| Hepatic comorbidity | ||
| No | 54 (16.4) | 239 (86.9) |
| Mild | 22 (8) | |
| Moderate/severe | 14 (5.1) | |
| IEI-associated complications (bronchiectasis, colitis, malignancy, GLILD, hepatic comorbidity, and splenectomy) | ||
| None | 56 (17) | 90 (33) |
| One complication | 99 (36.3) | |
| Two or more complications | 84 (30.8) | |
| HCT-CI (Sorror score) | ||
| 0 | 7 (2.1) | 89 (27.6) |
| 1-2 | 128 (39.8) | |
| 3-4 | 59 (18.3) | |
| >4 | 46 (14.3) | |
| . | Total (N = 329) . | |
|---|---|---|
| Missing (%) . | N (%)∗ . | |
| Patient sex | ||
| Male | 0 | 223 (67.8) |
| Female | 0 | 106 (32.2) |
| IEI subgroup | ||
| CID | 0 | 163 (49.5) |
| PD | 0 | 127 (38.6) |
| PAD | 0 | 39 (11.9) |
| Age at HSCT (y) | ||
| Median (IQR) | 0 | 18.4 (16.6-22.8) |
| Time from clinical diagnosis to HSCT (mo) | ||
| Median (IQR) | 1 (0.3) | 63.1 (13-189.1) |
| Age at clinical diagnosis (y) | ||
| Median (IQR) | 3 (0.9) | 13 (3.6-17.2) |
| BMI at HSCT | ||
| Low BMI (<18) | 34 (10.3) | 74 (25.1) |
| Normal/high BMI (≥18) | 221 (74.9) | |
| Infection immediately prior to HSCT | ||
| No | 45 (13.7) | 136 (47.9) |
| Yes | 148 (52.1) | |
| Bronchiectasis at HSCT | ||
| Absent | 5 (1.5) | 238 (73.5) |
| Present | 86 (26.5) | |
| Colitis or protracted diarrhea at HSCT | ||
| Absent | 4 (1.2) | 255 (78.5) |
| Present | 70 (21.5) | |
| Malignancy prior to HSCT† | ||
| No | 5 (1.5) | 263 (80.9) |
| Yes | 62 (19.1) | |
| Remission status at HSCT (if prior malignancy) | ||
| No remission | 4 (5.6) | 23 (39.7) |
| Remission | 33 (56.9) | |
| Not evaluated | 2 (3.4) | |
| GLILD at HSCT | ||
| No | 18 (5.5) | 268 (86.2) |
| Yes | 43 (13.8) | |
| Splenectomy prior to HSCT | ||
| No | 14 (4.3) | 285 (90.5) |
| Yes | 30 (9.5) | |
| Hepatic comorbidity | ||
| No | 54 (16.4) | 239 (86.9) |
| Mild | 22 (8) | |
| Moderate/severe | 14 (5.1) | |
| IEI-associated complications (bronchiectasis, colitis, malignancy, GLILD, hepatic comorbidity, and splenectomy) | ||
| None | 56 (17) | 90 (33) |
| One complication | 99 (36.3) | |
| Two or more complications | 84 (30.8) | |
| HCT-CI (Sorror score) | ||
| 0 | 7 (2.1) | 89 (27.6) |
| 1-2 | 128 (39.8) | |
| 3-4 | 59 (18.3) | |
| >4 | 46 (14.3) | |